Trial Profile
Pharmacogenetics of Nicotine Addiction Treatment (PNAT)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Biomarker; Therapeutic Use
- Acronyms PNAT
- 03 Dec 2015 Number of treatment arms has changed from 3 to 6 as reported by ClinicalTrials.gov record.
- 03 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jan 2014 Planned number of patients changed from 1350 to 1200 as reported by ClinicalTrials.gov